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Abstract
Dose addition, a commonly used concept in toxicology for the prediction of chemical mixture effects, cannot readily be
applied to mixtures of partial agonists with differing maximal effects. Due to its mathematical features, effect levels that
exceed the maximal effect of the least efficacious compound present in the mixture, cannot be calculated. This poses
problems when dealing with mixtures likely to be encountered in realistic assessment situations where chemicals often
show differing maximal effects. To overcome this limitation, we developed a pragmatic solution that extrapolates the toxic
units of partial agonists to effect levels beyond their maximal efficacy. We extrapolated different additivity expectations that
reflect theoretically possible extremes and validated this approach with a mixture of 21 estrogenic chemicals in the E-
Screen. This assay measures the proliferation of human epithelial breast cancers. We found that the dose-response curves of
the estrogenic agents exhibited widely varying shapes, slopes and maximal effects, which made it necessary to extrapolate
mixture responses above 14% proliferation. Our toxic unit extrapolation approach predicted all mixture responses
accurately. It extends the applicability of dose addition to combinations of agents with differing saturating effects and
removes an important bottleneck that has severely hampered the use of dose addition in the past.
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Introduction
Dose addition (DA, here used synonymously with concentration
addition) is a widely used pharmacological concept for the
prediction of chemical mixture effects when only the toxicity of
individual components is known [1], [2]. Various risk assessment
methods for evaluating combined exposures are in use (e.g., toxic
equivalent factor approach, toxic unit summation, hazard index
and the point of departure index), and without exception all these
methods are derived from DA [3].For a wide variety of mixtures
and toxicological endpoints DA has proven remarkably successful
in formulating a dose additivity null hypothesis [4], [5]. This
hypothesis expresses the expected combination effect based on the
assumption that all mixture components exert their effects without
influencing each other’s action. Using the DA additivity hypothesis
as a point of reference, it is then possible to assess experimentally
observed mixture effects in terms of synergism or antagonisms.
Still lacking is sufficient empirical evidence about the joint action
of environmentally realistic mixtures, composed of agents from
different chemical and functional classes. This makes it difficult to
validate the assumption that DA might be applicable as a general
‘‘rule of thumb’’ for describing the joint action of chemical
mixtures. A crucial prerequisite is that the mathematical features
of DA are capable of dealing with these more difficult mixture
scenarios.
One such difficulty relates to mixtures composed of chemicals
that show differing maximal effects. Due to the mathematical
features of DA, the concept cannot be applied to effect levels that
exceed the maximal effect of the least efficacious compound
present in the mixture. As shown in Figure 1, this limits its
usefulness when dealing with mixtures composed of substances
that show partial agonism, where the effects at saturating
concentrations are somewhat smaller than is biologically achiev-
able. This has been observed with some aryl hydrocarbon receptor
(AhR) agonists and certain estrogenic agents [6], [7], [8], [9].
Similar problems occur when dealing with mixtures of chemicals
that show hormesis, as seen with phytotoxicants acting on plant
species [10].
Several attempts have been made to overcome these difficulties.
They all deal with the original mathematical formulation of DA
that defines a combination effect: a mixture composed of n
components with doses d1 of the first component, d2 of the second
component, and dn for the n-th component is dose additive when
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Here, EDX1, EDX1 …, EDXn are the doses of the individual
components that on their own produce the same effect X as the
mixture [11], [12]. These effect doses for a common effect level
have to be derived from regression models that describe the dose-
response relationships of all chemicals present in the mixture for
the effect of interest. The quotients dn/EDXn are called toxic units.
Equation 1 requires knowledge of the dose of each mixture
component that on its own produces the effect magnitude under
consideration. For this reason, equation 1 cannot be used for
predicting mixture effects that exceed the maximal effect of the
least efficacious component, because that effect dose cannot be
defined.
As can be seen from equation (1), a mixture effect for a pre-
defined effect level X is described implicitly and can rarely be
solved analytically. Only by using an iterative algorithm can the
solution be found numerically. However, under certain circum-
stances it is possible to re-arrange equation (1) into an explicit
expression such that the combined effect of the mixture is
described as a function of the effects of its components.
Consequently, any combination of full and partial agonists should
then allow the calculation of their combined effects and therefore
overcome the dilemma shown in Figure 1. Unfortunately, this
ideal scenario can only be achieved by making certain simplifying
assumptions about the regression models used for approximating
the dose-response relationships of individual mixture components
[13], [14], [15]. For example, Howard et al [14] utilized a
simplified version of the Hill function where instead of the usual
three parameters only two were used, one for maximal effect, and
the other for location (EC50). The slope parameter was kept fixed
for all chemicals, presumably because the agents under investiga-
tion displayed curves of similar steepness. Howard and colleagues
termed their solution ‘‘Generalized Concentration Addition’’
(GCA), and it afforded sufficient flexibility for the accurate
prediction of AhR-dependent gene expression for full and partial
AhR agonists, as well as competitive antagonists [15].
However, the simplifying assumptions that have to be made
during the modeling of dose-response relationships for the
individual mixture components may impact negatively on the
quality of mixture effect predictions under DA, particularly when
the biological data for the single chemicals require more complex
non-linear regression functions. This is the case with estrogenic
agents where dose-response curves with different slopes are
common [9], [16]. The most widely used regression functions
for dose-response analyses have at least three model parameters,
and these are usually needed for the adequate description of global
data differences in terms of position (potency), steepness and
maximal effect plateaus [17]. But with these non-linear regression
functions it is not possible to re-arrange equation (1) into an
explicit functional form that would allow for the analysis of partial
agonists, and therefore an extension of the CGA model on basis of
more flexible dose-response models cannot be achieved.
In view of these difficulties we became interested in exploring
alternative quantitative approaches for dealing with mixtures
composed of partial agonists. We reasoned that a straightforward
pragmatic solution could be found by extrapolating the dose-
response curves of partial agonists to higher effect levels beyond
their leveling-off range. The extrapolated effects could then be
used for the calculation of the dose addition null hypothesis. The
advantage of this approach is that it can accommodate quite
complex regression models for the dose-response data of the
individual mixture components. However, the use of extrapolation
methods is fraught with its own difficulties, particularly in relation
to the selection of an appropriate slope for the extrapolated dose-
response function. Too steep a gradient may overestimate the
contribution of the partial agonist to the overall mixture effect in
relation to the other mixture components, and consequently bias
the dose addition prediction. The challenge in using extrapolation
Figure 1. Example of dose-response curves from three mixture components (A) and their joint effect curve predicted by dose
addition (B), for serial dilutions of a mixture with fixed mixture ratio proportional to their EC40s.
doi:10.1371/journal.pone.0088808.g001
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methods lies in ensuring that the dose addition prediction is as
close as possible to the experimentally observed dose additive
effect. In principle, this can be achieved by providing a range of
potential additivity expectations, based on assumptions of the
value of the toxic units in equation (1) that reflect theoretically
possible extremes (‘‘toxic unit extrapolation’’).
We tested a mixture of 21 estrogenic chemicals and compared
the accuracy of mixture effect predictions derived from a toxic unit
extrapolation approach with those produced by the GCA method.
The estrogenic agents included compounds as diverse as steroidal
hormones (endogenous and synthetic), pesticides, cosmetic addi-
tives and phytoestrogens, all with dose-response curves that
exhibited widely varying shapes, slopes and maximal effects ([9],
[16]). The accuracy of both predictions was evaluated by
comparison with the combination effects observed experimentally
with the E-Screen, an assay sensitive to the proliferative effects of
estrogen receptor agonists in a human epithelial breast cancer cell
line, MCF-7 BOS [18]. Although cell proliferation offers the
possibility to study processes that might interfere with steroid
receptor signaling through events beyond estrogen receptor (ER)
binding (e.g., activation of growth factor signaling cascades), these
processes are believed to converge on the activation of the ER,
which ultimately is responsible for cell division and proliferation.
We consider, therefore, that the pharmacological assumption of
DA is fulfilled, i.e. all compounds act on the same toxicological
endpoint by a common mechanism of action. Accordingly, we
used DA as the mixture assessment concept for the evaluation of
our data.
Materials and Methods
Chemicals
17b-Estradiol (E2, 99% purity), estrone (99%), aldrin (98.6%),
dieldrin (99.8%), endosulfan a (I, 99.5%), endosulfan b (II, 99.2%),
methoxychlor (99.5%), o,p’-DDT (97.5%), o,p’-DDD (99%), p,p’-
DDT (99.1%), p,p’-DDE (99.5%), b-hexachlorocyclohexane (b-
HCH, 98.1%), n-butylparaben, n-propylparaben, and bisphenol A
(.99%) were purchased from Sigma-Aldrich Company (Dorset,
UK). 3-(4-methylbenzylidene)camphor (4-MBC, Eusolex 6300,
.99.7%) and octyl-methoxycinnamate (OMC, Eusolex 2292,
.98%) were from VWR international (Poole, UK). 3-Benzylidene
camphor (3-BC, Unisol-22, .97%) was from Induchem (Volk-
etswil, Switzerland). Genistein was obtained from Alfa Aesar
(Lancashire, UK), and 6-acetyl-1,1,2,4,4,7-hexamethyltetraline
(AHTN, tonalide) and hexahydrohexamethylcyclopentabenzo-
pyran (HHCB, Galoxolide) from LGC Promochem (Teddington,
UK). All chemicals were used as supplied and stock solutions (1 –
10 mM) were prepared in HPLC-grade ethanol (VWR interna-
tional). Stock solutions and subsequent dilutions were stored at
220uC. All remaining chemicals were purchased from Sigma-
Aldrich, unless stated otherwise.
Routine cell culture
MCF-7 BOS breast cancer cells were kindly provided by Ana
Soto (Tufts University, Boston), who cloned the cells (C7MCF-7)
from the original MCF-7 cells obtained from the Michigan Cancer
Foundation [18]. Cells were routinely maintained in 75 cm2
canted-neck tissue culture flasks in Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen Corporations, U.K.) supplemented
with 5% fetal bovine serum (FBS, Invitrogen) and 1% (v/v) MEM
nonessential amino acids (MEM-NEAA, Invitrogen) in a humid-
ified incubator, at 37uC, with 5% CO2. Cells were subcultured at
approximately 70% confluence over a maximum of 10 passages
and regularly tested for Mycoplasma contamination.
E-Screen assay procedure
The protocol described previously [9], carried out in 96-well
micro-titer plates, was used. A detailed description of the data
normalisation procedure that we employed can be found in [7].
All components and the mixture were tested in at least four
independent experiments, run on up to three micro-titer plates,
with each plate containing eight increasing concentrations of the
test chemical in duplicates. Some of the data for the single
components have been published in [16]. To ensure that none of
the 21 compounds dominated the overall mixture effect, they were
combined in proportion to their EC10 values, concentrations
associated with 10% of the maximal effect achievable with
saturating concentrations of 17b-estradiol. This effect level was
the highest common level for all compounds that we could
determine with high statistical certainty, and which was well above
the statistical detection limit of the assay. The exact composition of
the mixture analysed is given in Table 1.
Statistical dose response analysis
Statistical dose-response regression analyses for the single
substances and mixtures were conducted by using a best-fit
approach [17]. Various non-linear regression models (logit, probit
weibull, generalized logit I and II), which all describe monotonic
sigmoid dose-response relationships, were fitted independently to
the same data set and the best fitting model was selected on the
basis of a statistical goodness-of-fit criterion. Data analysis was
performed on pooled data from all the repeat studies. To account
for the intra- and inter-study variability associated with this nested
data scenario, the generalized non-linear mixed modelling
approach was used, in which both fixed and random effects are
permitted to have a non-linear relationship with the effect
endpoint [19]. For the normalised read-outs (cell number), two
sources for random effects were identified: First, the dose-response
data for the same chemical from different studies varied in their
curve steepness, which was dealt with by including an additional
random effect in the steepness model parameter. Secondly, slight
shifts of the entire curves based on the log10-transformed
concentration scale were observed, which was accounted for by
including an additional shift parameter as random effect in the
non-linear regression model. The random effects were assumed to
follow a Normal distribution. Statistical uncertainties for the
estimated effect doses were expressed as 95% confidence belts and
approximately determined by applying the bootstrap method [20].
Calculation of mixture effect predictions using dose
addition
The mixture experiments were designed according to the fixed-
ratio mixture design, i.e. serial dilutions of a stock solution of a
mixture with known mixture ratio were made and then tested
against the corresponding DA predictions. The mathematical and
statistical procedures used for calculating dose-additive mixture
effects according to Equation 1 are described in [7]. The statistical
uncertainty for the mixture effects predicted by DA was
determined using the bootstrap method [20] and expressed as
95% confidence limits for the predicted mean estimate. Differ-
ences between predicted and observed effect doses were deemed
statistically significant when the 95% confidence belts of the
prediction did not overlap with those of the experimentally
observed mixture effects.
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Description of the toxic unit extrapolation approach for a
fixed-ratio design
For dose ranges that are higher than the effect doses that
correspond to the leveling-off range of a partial agonist, the toxic
unit extrapolation approach supposes that partial agonists
contribute to the total mixture effect by a certain toxic unit. It
can be assumed that the value of this toxic unit will vary with total
mixture dose and will be different for different partial agonists
present in the mixture. It is not immediately obvious which
numerical values such toxic units should take, but it is reasonable
to suppose that the range of values lies between two extremes, as
follows: Firstly, it can be assumed that a partial agonist makes no
further contribution to the overall mixture effect when its dose in
the mixture approaches its individual saturation range. By using
the example sketched out in Figure 1, we have illustrated this
scenario in Figure 2 a. Here, toxic units for each of the three
components s1, s2 and s3 are plotted as a function of the overall
mixture effect. In this example, we have assumed that the three
substances are combined at a mixture ratio proportional to the
dose of each individual component that produces a 40% effect. It
can be seen that the toxic units for each component vary according
to the total predicted mixture effect. This is a reflection of the
different steepness of each compounds’ individual dose response
curve (see Figure 1 and equation 1). Under the additivity
assumption of DA, the sum of the toxic units corresponding to a
specific predicted combination effect (along the vertical lines in
Figure 2 a) must equal 1. Of special interest is the point where s1,
s2 and s3 have the same toxic unit of 0.333, i.e. where the three
toxic unit curves in Figure 2 a intersect. Because the mixture ratio
was set proportional to each compounds’ ED40, this point
corresponds to a mixture effect of 40%. As component s3
individually produces a maximal effect of only 50% (see
Figure 1), its toxic unit curve rapidly approaches zero as the total
mixture effect nears 50%. This is because the denominator of the
toxic unit term, i.e. the dose of the single compound that elicits an
effect equal to that of the mixture, will tend towards infinity as the
total mixture effect approaches the effect corresponding to the
saturation doses of the partial agonist (here: 50%). To meet the
demand of the additivity assumption of DA (i.e. the sum of toxic
units equals 1), the curves for the other two components must
increase steeply as the total mixture effects comes within reach of
50% (see Figure 2 a).
A second assumption can be made to mark the other extreme of
the theoretically possible range of toxic unit values for a partial
agonist at mixture doses that exceed its saturation range. Here, its
toxic unit is assumed to be fixed to a certain value corresponding
to its saturation range (maximum toxic unit assumption).
Calculations of predicted mixture effects under the maximum
toxic unit assumption require decisions about the numerical value
of a partial agonist’s toxic unit. We have dealt with this problem in
terms of setting the toxic unit for a partial agonist to predefined
Table 1. Estrogenicity of individual compounds and mixture.
Substance regression model EC10
Relative proportions
(percentages)
(by order of EC10) RM h^1 h^2 h^3 h^min h^max nM [CI] in test mixture
17b-estradiol Logit 3.32 1.76 -- 0* 0.99 7.56E-04 [5.63E-04;1.02E-03] 1.493E-06
Estrone Glogit I 0.50 2.59 0.8 0* 1.12 4.61E-02 [3.76E-02;6.09E-02] 1.081E-04
Genistein Logit 26.56 3.25 -- 0* 0.84 2.52E+01 [1.90E+01;4.40E+01] 5.907E-02
Bisphenol A Logit 27.23 2.72 -- 0* 0.92 7.61E+01 [5.64E+01;1.00E+02] 1.784E-01
o,p’-DDT Weibull 26.62 2.37 -- 0* 0.77 9.04E+01 [6.48E+01;1.50E+02] 2.119E-01
Butyl paraben Logit 28.77 2.53 -- 0* 0.88 4.28E+02 [3.25E+02;5.92E+02] 1.003E-00
Endosulfan a (I) Weibull 28.36 2.40 -- 0* 0.79 4.49E+02 [3.18E+02;6.67E+02] 1.053E-00
b-HCH Weibull 210.51 3.13 -- 0* 0.85 4.98E+02 [3.63E+02;6.01E+02] 1.167E-00
3-BC (Unisol S-22) Probit 26.62 2.02 -- 0* 0.73 5.39E+02 [4.50E+02;7.04E+02] 1.263E-00
o,p’-DDD Glogit I 215.02 4.56 0.8 0* 0.68 6.11E+02 [4.75E+02;8.41E+02] 1.432E-00
Endosulfan b (II) Weibull 210.82 3.19 -- 0* 0.61 7.52E+02 [6.08E+02;9.40E+02] 1.763E-00
Methoxychlor Glogit I 216.34 4.72 0.6 0* 0.50 8.09E+02 [5.78E+02;1.23E+03] 1.896E-00
Propyl paraben Logit 212.54 3.61 -- 0* 0.86 8.13E+02 [6.95E+02;8.88E+02] 1.905E-00
4-MBC (Eusolex 6300) Weibull 210.12 2.79 -- 0* 0.42 1.45E+03 [1.27E+03;2.15E+03] 3.399E-00
p,p’-DDT Glogit I 217.27 4.70 0.7 0* 0.50 1.63E+03 [1.31E+03;1.95E+03] 3.816E-00
Dieldrin Weibull 212.16 3.49 -- 0* 0.27 1.80E+03 [1.25E+03;2.72E+03] 4.212E-00
AHTN (Tonalide) Weibull 29.90 2.56 -- 0* 0.35 2.74E+03 [2.08E+03;3.57E+03] 6.444E-00
OMC (Eusolex 2292) Glogit I 24.30 1.69 6.4 0* 0.29 3.47E+03 [1.89E+03;7.57E+03] 8.143E-00
p,p’-DDE Glogit I 213.58 4.05 4.1 0* 0.41 3.71E+03 [3.42E+03;4.94E+03] 8.694E-00
Aldrin Glogit I 227.81 6.76 0.4 0* 0.20 7.64E+03 [6.21E+03;1.14E+04] 1.791E+01
HHCB (Galaxolide) Weibull 27.95 1.96 -- 0* 0.14 1.51E+04 [1.25E+04;2.00E+04] 3.545E+01
Mixture of 21 components Weibull 211.64 3.02 -- 0* 0.57 2.04E+03 [1.75E+03; 2.44E+03]
EC10: concentration associated with 10% proliferation rate. Values in brackets denote the upper and lower limits of the approximate 95% confidence interval based on
bootstrap replicates; the column ‘‘RM’’ indicates the mathematical regression function, used for describing the concentration response relationships (see [17] for more
details). h^1,h^2,h^3,h^min,h^max estimated model parameters, if marked by *, then held fixed, i.e. not estimated.
doi:10.1371/journal.pone.0088808.t001
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values corresponding to doses producing certain fractions of the
maximal effect level, for example 80%, 90% or 99%. With 50% as
the maximal effect, as in our example, this translates into 40%,
45% and 49.5% on the predicted mixture effect scale (see Figure 2
b). The corresponding toxic units for the partial agonist s3 can now
be read off the graph (Figure 2 b) by seeking the intersections of
the three vertical lines k1, k2 and k3 with the toxic unit curve for s3,
i.e. 0.333 (for 40% mixture effect), 0.29 (for 45% mixture effect)
Figure 2. Description of the toxic unit extrapolation method, demonstrated at the hypothetical 3-component mixture from
Figure 1: (A) toxic units of three compounds (s1, s2 and s3) for mixture effect predictions according to DA. The third compound has a
maximum effect of 50% (see Figure 1), thus predictions and toxic units above 50% cannot be calculated. (B) The toxic unit of the third compound is
held fixed at effect prediction of and above 49.5%, 45% and 40% (blue line), i.e. s3(k1), s3(k2) and s3(k3), respectively. The corresponding toxic units for
the first and second compound are shown as green and red lines, respectively. (C) Dose-response curves of the single compounds after the toxic unit
extrapolation, for three different fixed toxic units of the third compound at effect levels k1, k2 and k3. (D) Prediction curve for mixture effects
according to DA (solid line), prediction curves of the toxic unit extrapolation assuming maximal toxic unit contributions of the third compound as
outlined in B and D (small lines) and assuming no contribution after 50% (dashed line). For details, see Materials and Methods.
doi:10.1371/journal.pone.0088808.g002
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and 0.15 (for 49.5% mixture effect). These values represent three
choices for the maximal contribution of s3 to the overall mixture
effect beyond its own saturation level. The choice of a particular
maximum toxic unit for the partial agonist restricts the range of
toxic unit values that the remaining two mixture components can
assume (the sum of toxic units must still be 1). If, for example, the
toxic unit for the partial agonist s3 is set fixed to 0.333 for all
predicted mixture effects from 40% to 100%, then the sum of toxic
units left to be allocated to s1 and s2 cannot be greater than 0.666.
This value is subsequently distributed between s1 and s2 according
to equation 1. The differences between the toxic unit curves for s1
and s2 reflect the differences in the steepness of the dose-response
curves for s1 and s2 at high effect levels (see Figure 1A). The
contribution of compounds with a comparatively shallow dose-
response curve (in our case s2) to the predicted mixture effect
usually decreases with increasing mixture doses, except where all
mixture compounds have equally shallow dose-response curves.
Figure 2 c shows the dose-response curve for the partial agonist
s3 together with the extrapolated curves that result according to
the minimal toxic unit assumption and the various fixed values
under the maximum toxic unit assumption. These extrapolations
are used to calculate the expected additive effects according to DA
beyond the leveling-off range of s3. The extrapolated curves for s3
are not all smooth, but the one corresponding to the highest toxic
unit contribution and the smallest fraction of the maximal effect,
k1 and 80%, respectively, gives the smoothest continuation of s3
dose-response curve. In deriving the maximal toxic unit assump-
tion from the experimental data with the 21-component mixture of
estrogenic chemicals, we have fixed the toxic unit to that
corresponding to 70% of the saturation effect of each partial
agonist. The choice of this value was guided by effect levels at
which the highest steepness of the non-linear regression functions
was observed: for symmetrical functions (e.g., logit) it is half of
their maximal model asymptote (50%), whereas for asymmetrical
models (e.g., Generalized logit) it was up to 70% of their maximal
effect plateau. We performed simulation studies to investigate the
optimal cut-off level, and unless the least efficacious compound
dominated the mixture composition, we found the value of 70% to
be the best trade-off between safeguarding that the toxic unit
contribution was really maximal and a sufficient response range
used for the prediction by DA. Therefore we recommend this
value as default for all data situations where the saturation effect
has been estimated with high confidence.
Finally, the range of DA prediction curves derived from the
minimum and the various maximum toxic unit assumptions is
shown in (Figure 2 d). The bold line represents the anticipated
combination effects according to the conventional approach (as in
Figure 1), and the thin lines show the predicted effects resulting
from the maximum toxic unit assumptions for the three cut-off
values above. The thin dashed line depicts the predicted
combination effects according to the minimum toxic unit
assumption. Although the three different maximum worst-case
settings resulted in very different dose-response curves for the third
component (Figure 2C), the differences in the prediction curves
are rather small. Moreover, the range of predicted mixture effects
between the minimum and most conservative maximum toxic unit
assumption is small. The leveling-off range for the mixture dose-
response curve cannot be calculated using our toxic unit
extrapolation approach.
Mathematical treatment of the toxic unit extrapolation
approach
Mathematically, the approach can be described as follows: for
simplicity’s sake, suppose that only the nth component of the n-
compound mixture is a partial agonist. Suppose further that the
experimental design for the mixture study is the ‘ray design.’ A ray
is defined by a fixed mixing ratio of the components in a specified
mixture. Depending on whether the dose dn of the n
th component
in the mixture exceeds the cut-off dose Dn along a fixed ratio ray,
dose additivity can be described according to the terminology of
Equation 1 as
dnƒDn :
d1
EDX1
z
d2
EDX2
z:::z
dn
EDXn
~1
dnwDn :
d1
EDX1
z
d2
EDX2
z:::zTUXn~1 :
ð2Þ
Here, the toxic unit TUXn of the partial agonist is set to a fixed
value, with
TUXn~
dn
KXn
, ð3Þ
where KXn is the dose that is extrapolated to the effect level X. The
limitation to the fixed-ratio design guarantees a unique solution
(assuming that only monotonic dose-response relationships are
considered). The cut-off dose Dn was selected in our study as dose
that produces 70% of the saturation effect. Assuming that the
dose-response relationship of the partial agonist can be described
by a monotonic function Fn and the maximal effect level by a
parameter estimate h^max [17], the cut-off dose Dn can then be
estimated through the inverse function F{1n as
Dn~F
{1
n (0:7  h^max) : ð4Þ
Consequently, an effect level of x = 0.7* h^max is set as borderline
for calculating dose additive response according to DA (Equation
1).
Adaptation of the Generalised Concentration Addition
(GCA) model
We have generalised the GCA model as originally described by
[14] for a mixture composed of n components, as follows: Let himax
and ED50i be the Hill model parameters for the i
th component
describing the maximal effect level and the median effect dose,
respectively. The Hill function with slope parameter 1 then
describes the response E at a given dose d1 as
E(d1)~
hmaxd1
ED501zd1
: ð5Þ
According to [14] (Equation 17), the combined effect for a
binary mixture at given total mixture dose dmixture can then be
described as
E(dmixture)~E(d1zd2)~
d1  h1max=ED501zd2 h2max=ED502
1zd1=ED501zd2=ED502
: ð6Þ
Assuming that the individual doses of all components as present
in the mixture can be expressed as fractions p of the total mixture
dose dmixture, with di = pi*dmixture (fixed-ratio mixture design), the
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dose-additive mixture effect can be calculated for a n-component
mixture as
E(dmixture)~
Pn
i~1
(di  himax=ED50i)
1z
Pn
i~1
(di=ED50i)
~
dmixture
Pn
i~1
(pi  himax=ED50i)
1zdmixture
Pn
i~1
(pi=ED50i)
:
ð7Þ
Increasing mixture doses to infinity, we get the maximal effect
level Emax:
Emax : lim
dmixture??
E(dmixture)~
Pn
i~1
(pi  himax=ED50i)
Pn
i~1
(pi=ED50i)
: ð8Þ
Results
We conducted extensive concentration-response analyses with
all the 21 individual chemicals that were included in the mixture.
In the interest of providing unbiased response curves for the
calculation of expected mixture responses, we used a variety of
regression models and selected the best-fitting model for each
chemical [17]. The model parameters and effect concentrations
are shown in Table 1; some of the data have been published in
[16]. Figure 3 shows the best-fitting regression curves for all 21 test
components, covering only the non-toxic concentration ranges
that were tested experimentally. Most compounds were tested at
higher concentrations, but where proliferation responses began to
decline as concentrations increased, the data points were judged as
cytotoxic and were not included in constructing concentration-
response models. The concentration-response curves of the 21
chemicals showed differences in terms of shape, gradient and
position, with 17b-estradiol the most potent component
(EC10= 0.00076 nM) and the synthetic musk galaxolide the
weakest (EC10=15.1 mM). Differences in maximal effects ranged
from 100% for the steroids to only 14% for galaxolide. A further 8
chemicals showed maximal effects ranging from 20% to approx-
imately 50% proliferation.
All chemicals were mixed at a ratio proportional to their
individual EC10 values. We first predicted the combination effects
of the 21 chemicals by using the conventional DA concept
(equation 1). As expected, this yielded a curve for responses of up
to 14%, the maximal effect of the least efficacious component in
the mixture, galaxolide (Figure 4, red curve). Due to the large
number of repeats in the concentration-response data that formed
the basis of the regression analysis of the single components, we
were able to produce a DA prediction curve of very low statistical
uncertainty (dotted red lines in Figure 4). The width of the 95%
confidence belt of the prediction never exceeded 2% on the effect
scale.
By using the toxic unit extrapolation approach, it was possible to
extend the effect range of the prediction from 14% to between
approximately 50% (minimum toxic unit assumption) and 70%
(maximum toxic unit assumption) of those seen with the positive
control (saturating concentrations of 17b-estradiol) (Figure 4). For
the extrapolation of mixture effects according to the maximum
toxic unit assumption, we fixed the toxic unit of each single partial
agonists to a value associated with 70% of its maximal effect
plateau, as estimated from the regression models (Table 1). For
extrapolations derived from the minimum toxic unit assumption,
toxic units were set to zero (Equation 3).
The predictions were then tested experimentally. The experi-
mental data showed comparatively little variation in the low
concentration range, but variation increased as the mixture effect
curve approached its plateau with a maximal cell proliferation of
approximately 55%.
Over the entire range of observations, the predicted combina-
tion effects agreed very well with the experimentally observed data
(Figure 4), both for the predictions derived from Equation 1 (red
curve) and for those from the toxic unit extrapolation approaches
(green curves). For a total mixture concentration of 10,000 nM,
the DA predictions according to the minimum and maximum
toxic unit assumptions spanned responses of between 35% and
45% proliferation, respectively. The experimentally observed
effects generally agreed better with the extrapolation derived from
the maximum toxic unit assumption.
Figure 5 shows a comparison of the experimental mixture data
with the prediction derived from the GCA approach based on Hill
functions for all components’ individual dose-response data. Here,
the prediction curve from the toxic unit extrapolation approach is
not included. At low concentrations, the GCA overestimated the
observed responses, but at higher concentrations the GCA model
underestimated the proliferative effects of the mixture. The model
predicted a maximal response of 41%. Had we used our toxic unit
extrapolation approach based only on Hill functions (with
steepness model parameters fixed to 1), and not with the variety
of regression models shown above, we would have obtained a
curve very similar to the one shown in Figure 5, with its
overestimation of combination effects in the low concentration
range (data not shown). This highlights the importance of accurate
descriptions of dose-response relationships for each mixture
component for achieving valid mixture effect predictions.
Discussion
We show that the toxic unit extrapolation approach is able to
produce DA predictions that agree very well with our experimen-
tally observed data. The approach affords sufficient flexibility for
dealing with mixture components that exhibit concentration-
response relationships with varied slopes, positions and maximal
effects. Our findings help to dispel the widespread misconception
that DA is only applicable to mixtures composed of chemicals that
show parallel response curves. However, the general formulation
of DA neither assumes a specific shape of each concentration-
response curve of the components, nor a specific relationship
between the curves. The general application of DA is sometimes
confused with ‘‘simple similar action’’, a special case of DA which
requires that the individual curves of the components are dose-
parallel, as in the ‘‘toxic equivalence factor’’ (TEF) concept. Dose-
parallel curves occur with endpoints relatively close to molecular
events, such as receptor binding or receptor activation, but often
do not appear effects representative of higher levels of biological
organisation. The lack of parallelity with apical endpoints may be
explained in terms of differences in the toxicokinetic and
toxicodynamic behaviour of substances. Such phenomena are
relevant to the E-Screen assay where differential uptake,
metabolism and transport out of the cells may lead to non-parallel
curves. Furthermore, the E-Screen is more integrative assay than
e.g. an ER binding assay, and responds not only to the classical
activation of the ER by direct binding of the ligand, but also to
indirect activation, such as phosphorylation by protein kinases.
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Figure 3. Concentration-response curves for the 21 tested estrogenic chemicals with regression lines derived from the best fitting
models for E-Screen in vitro data. All agents were tested in at least four independent experiments, run on up to three micro-titer plates, with each
plate containing eight increasing concentrations of the test chemical in duplicates (data not shown).
doi:10.1371/journal.pone.0088808.g003
Figure 4. Predicted and observed estrogenic activity of a mixture of 21 components combined according to their individual EC10.
Observed mixture effects (black circles), controls (gray circles) and regression curve (solid black line, with 95% confidence belt as dotted black lines)
are from four independent experiments, each tested on three micro-titer plates. Effect variation is expressed by box and whisker diagrams; the boxes
show 1.5 interquartile ranges around the median. Predicted effects were calculated using the DA concept (solid red line), dotted red lines show the
corresponding approximate 95% confidence belt. The green lines and the green shaded area are the lower and upper estimates of predictions that
are based on toxic unit extrapolations (see Material & Methods for details).
doi:10.1371/journal.pone.0088808.g004
Dose Addition Mixture Model for Partial Agonists
PLOS ONE | www.plosone.org 8 February 2014 | Volume 9 | Issue 2 | e88808
We noticed that the predictions derived from the minimum
toxic unit assumption, where partial agonists are presumed to
contribute nothing to the overall mixture effect at doses beyond
their saturation ranges, did not perform as well as the maximum
toxic unit assumption. This may be a reflection of biological
realities: Partial agonists will still make a contribution to the overall
mixture effect when their doses fall in their leveling-off range, a
phenomenon that the minimum toxic unit assumption is by
definition unable to capture. Even so, it is striking that the
prediction differences between the two extremes of extrapolations
were not very large, particularly not in the range of mixture doses
up to the median effect level of the mixture response curve.
If the maximum toxic unit assumption is better suited to deal
with mixture scenarios that require flexible regression models for
describing accurately dose-response relationships, it is all the more
important to consider the implications in terms of data require-
ments and data quality. As detailed during the description of the
toxic unit extrapolation approach, the choice of the highest effect
dose for each partial agonist component that can be considered
acceptable for DA predictions is crucial. In our study we
consistently used the same cut-off criterion, i.e. 70% of the
maximum effect level. Thus, the quality of prediction strongly
depends on accurate estimations of the saturating effect levels for
each compound. In regression analysis, this approximation is
achieved by estimating the maximum asymptotic model parameter
(h^max in Table 1), but this requires effect data of sufficient quality.
With the E-Screen assay this may sometimes be problematic, for
two reasons: firstly, between-study data variation is highest for
high effect levels, i.e. more data is needed to achieve effect
estimates for higher concentrations that are statistically compara-
ble with low effect estimates. Secondly, at concentrations nearing
the saturation range cytotoxicity may become prominent, and this
may result in a down-turn of effects, such that the maximal effect
plateau occurs only in a narrow range of concentrations. This
phenomenon has been observed with certain estrogenic chemicals
[9]. In such situations, the quality of estimating saturating effect
levels strongly depends on the spacing of the tested concentrations,
which has to be done judiciously. However, these complications
were not relevant with the estrogenic chemicals included in our
mixture.
The alternative CGA model did not produce mixture effect
predictions of high accuracy and proved to be inferior to our toxic
unit extrapolation approach. To a very large degree, this was due
to the problems we encountered in using the Hill function as the
regression model for the single components in our mixture. We
observed that the Hill function generally produced regression
models with poorer goodness of fit than the regression models
selected by the best-fit approach [17]. The Hill function generally
overestimated the single component’s effects at low concentrations
(data not shown). Perhaps due to the fact that it has a symmetrical
shape, it lacks the flexibility to accurately approximate the effects
of the tested chemicals, particularly in the low dose range. This
may explain why the CGA model, which relies on the Hill
function with slope parameter 1, consistently overestimated the
observed mixture responses at low effects. Mathematically, DA is
an averaging concept, with the predicted effect doses correspond-
ing to the weighted harmonic mean of all individual effect doses,
where the weights relate to the fractions of the individual
Figure 5. Predicted and observed estrogenic activity of the mixture of 21 components shown in Figure 4. The predicted effects were
calculated using the model of DA (solid red line) according to the GCA approach by [14]. Observed mixture effects (black circles) and controls (gray
circles) are from four independent experiments, each tested on three micro-titer plates. Effect variation is expressed by box and whisker diagrams; the
boxes show 1.5 interquartile ranges around the median.
doi:10.1371/journal.pone.0088808.g005
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compounds in the mixture. Therefore, if the regression model for
the single components always produces systematic errors in the
same direction, the DA prediction will be biased in the same way,
as was indeed observed with the CGA model (Figure 5). The
advantage of the CGA method is in its comparative ease of use,
with less demanding calculations. This method will therefore be
appropriate when the mixture components exhibit dose-response
curves with similar gradients, or when less accurate predictions are
judged to be sufficient.
The mixture of 21 estrogenic chemicals showed proliferation
responses that were matched accurately by the prediction
according to DA and, at higher effect concentrations, according
to the toxic unit extrapolation method. These outcomes confirm
those from previous studies ([7]; [16]), where DA approximated
well the observed response from various multi-component
mixtures of estrogenic agents, suggesting that for cell proliferation
and testing conditions defined by the E-Screen assay the
pharmacological requirements of ‘‘similar action’’ of the DA
concept were fulfilled. We applied the DA extrapolation approach
also successfully to multi-component mixture studies in various
other in vitro testing systems, e.g. on reporter-gene endpoints for
estrogenicity (ERLUX) [21] and anti-androgenicity (MDA-kb2)
[22]. Experimental evidence also suggests that potential pharma-
cokinetic or dynamic ‘‘interactions’’ between compounds were not
pronounced enough to become detectable which would have
diminished the predictive power of DA. Considering that the E-
SCREEN represents the highest level of biological complexity of
all the in vitro assays in use for the screening of endocrine active
chemicals and taking into account the large numbers of chemicals
with varied structural features that were tested in combination, we
conclude that DA provides reasonable approximations for
combination effects of estrogenic chemicals with the endpoint of
cell proliferation. In addition, our study has demonstrated that the
toxic unit extrapolation method is capable of extending the
applicability of DA to combinations of agents with differing
saturating effects. The E-Screen is considered as a biomarker for
internal EDC exposure and the toxic unit prediction tool
developed here will be useful to estimate the combined internal
effective doses in humans on the basis of chemical analytical data
of tissue levels of multiple estrogenic agents. Estimations of
combined effects can now include compounds that exhibit much
lower maximal effect responses than the reference compound
estradiol. Our new approach thus overcomes a limitation which
has previously hampered the estimation of cumulative internal
EDC exposures. The new method can also be applied to other
classes of environmental pollutants, with other effect profiles.
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